双A破坏PPARG活动和CPT1A调节:对肝脂代谢的影响
Xiliang Zhu1, Qi Liu2, Zhaoyun Cheng1
1Department of Cardiovascular Surgery, Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Fuwai Central-China Cardiovascular Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, China.
双A (BPA) 通过改变基因表达和抑制PPARG活性来破坏肝功能. 这种内分泌干扰剂会影响肝脏脂质代谢,即使是低剂量.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 分子生物学分子生物学
背景情况:
- 双A (BPA) 是一种工业化学物质,具有已知的内分泌干扰特性.
- 代谢过程,特别是肝功能,容易受到环境化学物质的干扰.
- 了解BPA的分子机制对于评估其健康风险至关重要.
研究的目的:
- 研究双A (BPA) 对肝功能和转录调节的影响.
- 阐明BPA和氧酶增殖器激活受体玛 (PPARG) 之间的相互作用.
- 评估BPA对肝细胞和组织中的脂质代谢的影响.
主要方法:
- 雄性小鼠和AML12细胞暴露于不同剂量的BPA.
- 肝脏组织的转录组分析和组织学检查.
- 路西法酶记者测定,分子对接,MD模拟,DARTS,CETSA和MM-PBSA计算来分析BPA-PPARG相互作用.
主要成果:
- 暴露于BPA导致小鼠肝脏中差异表达基因的剂量依赖性下降.
- 低剂量的BPA显著降低了肝脏Cpt1amRNA水平.
- 在细胞系和肝脏组织中,BPA始终抑制了PPARG转录活性,高剂量导致脂质真空形成.
结论:
- 乙作为内分泌干扰剂,显著影响肝脂代谢和PPARG活性.
- 这项研究表明,BPA干扰肝脏的关键代谢途径.
- 需要进一步的研究,以了解BPA暴露对肝脏健康的长期影响.
更多相关视频
09:20Isolation and Differentiation of Adipose-Derived Stem Cells from Porcine Subcutaneous Adipose Tissues
Published on: March 31, 2016
08:28Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
Published on: April 26, 2018
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cell Specific Gene Expression
Cholesterol: Significance and Regulation
Considering cholesterol and...
GPCRs Regulate Adenylyl Cylase Activity
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
The drug's acidity or basicity is essential in...
